Get started
Author

Feifei Gu

Observed names: Fei-Fei Gu, Fei-fei Gu, Gu, Feifei
OpenAlex ID: A5101198523
Identification of Deleterious NOTCH Mutation as Novel Predictor to Efficacious Immunotherapy in NSCLC
2020 · Kai Zhang, Xiaohua Hong, et al. · Clinical Cancer Research · 120
The efficacy and toxicity profile of metronomic chemotherapy for metastatic breast cancer: A meta-analysis
2017 · Yangyang Liu, Feifei Gu, et al. · PLoS ONE · 47
PDF
Lung adenocarcinoma harboring concomitant SPTBN1-ALK fusion, c-Met overexpression, and HER-2 amplification with inherent resistance to crizotinib, chemotherapy, and radiotherapy
2016 · Fei-fei Gu, Yong Zhang, et al. · Journal of Hematology & Oncology · 40
PDF
Phenotypic and clinical characterization of low density neutrophils in patients with advanced lung adenocarcinoma
2017 · Yangyang Liu, Yue Hu, et al. · Oncotarget · 35
PDF
The Superior Ability of Human BDCA3+ (CD141+) Dendritic Cells (DCs) to Cross-Present Antigens Derived From Necrotic Lung Cancer Cells
2020 · Fei-fei Gu, Kai Zhang, et al. · Frontiers in Immunology · 22
PDF
FOXA1+ regulatory T cells: A novel T cell subset that suppresses antitumor immunity in lung cancer
2019 · Jinyan Liang, Chen Tian, et al. · Biochemical and Biophysical Research Communications · 22
PDF
Human inflammatory dendritic cells in malignant pleural effusions induce Th1 cell differentiation
2020 · Fei-fei Gu, Jing-jing Wu, et al. · Cancer Immunology Immunotherapy · 21
PDF
Identification of Clonal Neoantigens Derived From Driver Mutations in an EGFR-Mutated Lung Cancer Patient Benefitting From Anti-PD-1
2020 · Di Wu, Yangyang Liu, et al. · Frontiers in Immunology · 18
PDF
The Efficacy of First-Generation EGFR-TKI Combined With Brain Radiotherapy as the First-Line Treatment for Lung Adenocarcinoma Patients With Brain Metastases and EGFR Sensitive Mutations: A Retrospective study
2021 · Yuting Liu, Juanjuan Wang, et al. · Technology in Cancer Research & Treatment · 17
PDF
Identification of CXCL13/CXCR5 axis’s crucial and complex effect in human lung adenocarcinoma
2021 · Chen Tian, Chang Li, et al. · International Immunopharmacology · 15
Machine learning and bioinformatics analysis revealed classification and potential treatment strategy in stage 3–4 NSCLC patients
2022 · Chang Li, Chen Tian, et al. · BMC Medical Genomics · 9
PDF
Application of metabolomics by UHPLC-MS/MS in diagnostics and biomarker discovery of non-small cell lung cancer
2019 · Yuting Liu, Jingjing Wu, et al. · Translational Cancer Research · 9
PDF
Comprehensive Profiling Reveals Distinct Microenvironment and Metabolism Characterization of Lung Adenocarcinoma
2021 · Chang Li, Chen Tian, et al. · Frontiers in Genetics · 5
A hybrid of B and T lymphoblastic cell line could potentially substitute dendritic cells to efficiently expand out Her-2/neu-specific cytotoxic T lymphocytes from advanced breast cancer patients in vitro
2017 · Sheng Chen, Feifei Gu, et al. · Journal of Hematology & Oncology · 5
PDF
Integrated Analysis of MATH-Based Subtypes Reveals a Novel Screening Strategy for Early-Stage Lung Adenocarcinoma
2022 · Chang Li, Chen Tian, et al. · Frontiers in Cell and Developmental Biology · 4
Clinical value of MLH1-negative circulating tumor cells in lung cancer patients
2019 · Jin-Yan Liang, Qi-Fan Yang, et al. · Medicine · 4
Construction and validation of a novel prognostic nomogram for predicting overall survival in lung adenocarcinoma patients with different patterns of metastasis
2023 · Ying Xiong, Feifei Gu, et al. · Journal of Cancer Research and Clinical Oncology · 3
PDF
Marked response to nab-paclitaxel in EGFR mutated lung neuroendocrine carcinoma
2017 · Jin-Yan Liang, Fan Tong, et al. · Medicine · 2
YAP1‑mediated cytoplasmic‑nuclear translocation of SREBP2 promotes colorectal cancer via regulation of cholesterol metabolism
2026 · Luhui Zhong, Min Sun, et al. · International Journal of Oncology
Corrigendum: Comprehensive profiling reveals distinct microenvironment and metabolism characterization of lung adenocarcinoma
2025 · Chang Li, Chen Tian, et al. · Frontiers in Genetics
PDF
Immunotherapy beyond progression following first‑line chemotherapy plus immunotherapy in advanced non‑small cell lung cancer: A retrospective study
2024 · Xinyue Gu, Yue Hu, et al. · Oncology Letters
PDF
Supplementary Figures from Identification of Deleterious NOTCH Mutation as Novel Predictor to Efficacious Immunotherapy in NSCLC
2023 · Kai Zhang, Xiaohua Hong, et al.
Supplementary Materials from Identification of Deleterious NOTCH Mutation as Novel Predictor to Efficacious Immunotherapy in NSCLC
2023 · Kai Zhang, Xiaohua Hong, et al.
Data from Identification of Deleterious NOTCH Mutation as Novel Predictor to Efficacious Immunotherapy in NSCLC
2023 · Kai Zhang, Xiaohua Hong, et al.
Data from Identification of Deleterious NOTCH Mutation as Novel Predictor to Efficacious Immunotherapy in NSCLC
2023 · Kai Zhang, Xiaohua Hong, et al.
Works count: 29
Citation count: 397
H-index: 10
I10-index: 10
Year
Topic
Type